Canada-Israel Technology Cooperation Opens Global Markets for Collaborating Firms in Smart Health, Transportation and Cities

Canada-Israel Industrial Research & Development FoundationNewsCanada-Israel Technology Cooperation Opens Global Markets for Collaborating Firms in Smart Health, Transportation and Cities
24 April 2019
24 April 2019 Posted by truecourse News

The Canada-Israel Industrial Research and Development Foundation (CIIRDF) Announces Seven New Bilateral R&D Projects Valued at Almost $10 Million

OTTAWA, Ontario and TEL AVIV, Israel; April 25, 2019 – The Canada-Israel Industrial Research and Development Foundation (CIIRDF) today announced seven new bilateral R&D projects valued over $10 million.

With a goal to develop and commercialize new products and services for global markets, these bilateral projects harness the technology strengths and knowledge of 22 Canadian and Israeli firms and research partners. Leveraging $4.28 million from CIIRDF, these R&D teams will co-create new technology-based solutions that address key challenges in life sciences, artificial intelligence, clean tech, cybersecurity, and information and communications technologies (ICT). Downstream, these solutions will result in sales and revenues that generate significant return on this Canada-Israel investment. In turn, this will create new jobs, drive greater market share, provide new expertise, and deliver long-term economic benefit to both countries.

Following a rigorous evaluation and selection process involving expert reviewers in Canada and Israel, the CIIRDF Board of Directors approved funding for seven industry-led projects earlier this year. These bilateral teams include:

  • Amika Mobile (Canada) and Mobility Insight (Israel) for the development of a next-generation Intelligent Border Crossing and Connected Vehicle System that reduces border congestion, improves traffic flow, increases safety and reduces pollution;
  • Redlen Technologies (Canada) and Spectrum Dynamics Medical (Israel) for the creation a novel radiation detection and imaging platform that offers higher resolution full body digital imaging with lower radiation levels, and reduces patient scanning time;
  • MangoGen Pharma (Canada) and Orgenesis (Israel) for the development of a baculoviral delivery and encapsulation platform that increases the potency and performance of autologous insulin producing cells for treating diabetes, potentially enhancing manufacturing processes and reducing the cost of goods for cell therapies;
  • Enerkem (Canada) and DOR Chemicals (Israel) for a study that assesses the feasibility of using Enerkem technology to convert Israeli municipal solid waste into alternative transportation fuels, methanol and other renewable chemicals;
  • IS5 Communications (Canada) and Radiflow (Israel) for the development of advanced industrial networking solutions with integrated cyber security for the next-generation of industry infrastructure in the Internet of Things (IoT) era spanning manufacturing, smart cities, transportation and energy management;
  • Materium (Canada) and Aqwise (Israel) for the creation of a cleantech solution that enables water utility companies and wastewater treatment plants to successfully remove micro-pollutants from water in a cost-effective and environmentally friendly way; and
  • Visual Defence (Canada) and Seraphim Optronics (Israel) for the development of an economical, easy to install, intelligent perimeter intrusion detection system that would require less energy and significantly reduce the occurrence of false alarms using deep learning.

With equal representation from Canada and Israel, the CIIRDF Board of Directors provides final authorization on R&D project proposals that meet key eligibility requirements and pass the rigorous independent technical and business merit reviews performed in both countries. CIIRDF supports bilateral R&D initiatives by contributing up to 50 percent of joint project costs, to a maximum of CDN $800,000. The Canadian funding for the bilateral R&D technology commercialization initiatives is provided through the Canadian International Innovation Program (CIIP).

“For more than 20 years, CIIRDF has supported industry-led R&D cooperation among Canadian and Israeli firms that combine technologies and expertise for the joint development of new innovative products,” said Dr. Henri Rothschild, President of CIIRDF. “The seven projects announced build on technological strengths across Canada and Israel, including cybersecurity, AI and machine learning, SaaS (Software as a Service), biotech and the Internet of Things (IoT). The emerging commercial products will increase the competitiveness of collaborating firms, enabling them to generate new revenues and create new high value jobs. This will further strengthen the economies of Canada and Israel.”

“Canada represents a critical science, technology and commercialization partner for Israel,” said Mr. Aharon Aharon, CEO of the Israel Innovation Authority and Chair of CIIRDF. “Israel invests more significantly in civilian R&D than any other country in the world. These new Canada-Israel projects directly support Israel’s S&T and economic goals, as well as the vision and mission established by CIIRDF. Building on the impactful 130 collaborations supported by CIIRDF to date, these projects will help partnering tech firms capture lucrative markets beyond their borders and build our national knowledge-based economies.”

About the Canada-Israel Industrial Foundation (CIIRDF)

The Canada-Israel Industrial R&D Foundation (CIIRDF) promotes, stimulates and invests in collaborative research and development between companies in Canada and Israel, with a focus on the commercialization of new technologies. Established in 1994 as a mechanism to implement a formal treaty between the Governments of Canada and Israel, CIIRDF is connected institutionally with the Israel Innovation Authority (the former Office of the Chief Scientist in Israel’s Ministry of the Economy). CIIRDF has financed more than 130 collaborative R&D projects that have contributed to the joint development and sale of more than 60 new global products. This has generated hundreds of millions of dollars in economic value for Canadian and Israeli companies over the past decade. For additional information, please visit: www.ciirdf.ca

About the Israel Innovation Authority

The Israel Innovation Authority, formerly known as the Office of the Chief Scientist of the Ministry of Economy (& MATIMOP), is an independent and impartial public entity that operates for the benefit of the 3 Israeli innovation ecosystem and Israeli economy as a whole. Its role is to nurture and develop Israeli innovation resources, while creating and strengthening the infrastructure and framework needed to support the entire knowledge industry. For additional information, please visit: https://innovationisrael.org.il/en/

About the Canadian International Innovation Program (CIIP)

CIIP fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development. CIIP is a funding program offered by Global Affairs Canada and is delivered in collaboration with the National Research Council of Canada Industrial Research Assistance Program (NRCIRAP) for Brazil, China, India and South Korea. The program is delivered by The Canada-Israel Industrial Research and Development Foundation (CIIRDF) for Israel. For additional information, please visit: http://tradecommissioner.gc.ca/funding-financement/ciip-pcii/index.aspx?lang=eng

Media inquiries:
Sonya Shorey
Communications Strategist, CIIRDF
Cell: 613.851.9416
sonyashorey@ciirdf.ca